Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 26, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the reasons behind unexplained recurrent miscarriages (RCF), which is when a woman experiences three or more miscarriages before 14 weeks of pregnancy. Researchers believe that various factors, such as genetic issues, uterine problems, hormonal imbalances, or immune system responses, could contribute to these losses. The study aims to create a group of women with RCF to explore these factors further, especially since about half of the cases are currently unexplained.
To participate in this trial, women aged 18 to 50 who have had at least three miscarriages may be eligible. Participants will be asked to sign a consent form and provide information about their health. While the trial is not yet recruiting participants, those who join can expect to contribute to important research that may help improve understanding and treatment for women experiencing recurrent miscarriages.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18 to 50 years
- • Patients with at least 3 recurrent miscarriages
- • Signed consent form
- Exclusion Criteria:
- • - Patients who don't accept the use of their data
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Arsene MEKINIAN, MD, PhD
Principal Investigator
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials